The Food and Drug Administration cleared Heartflow's technology to quantify coronary plaque and the platform is now available, the company said.
Dr. Peder Myhre: Welcome listeners to this week's issue of Circulation on the Run, the week of September 23. I am Dr. Peder ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback